Maxigen Biotech Inc
TWSE:1783

Watchlist Manager
Maxigen Biotech Inc Logo
Maxigen Biotech Inc
TWSE:1783
Watchlist
Price: 41.9 TWD 0.12% Market Closed
Market Cap: 3.7B TWD
Have any thoughts about
Maxigen Biotech Inc?
Write Note

Gross Margin
Maxigen Biotech Inc

68.1%
Current
60%
Average
31.6%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
68.1%
=
Gross Profit
415.1m
/
Revenue
609.2m

Gross Margin Across Competitors

Country TW
Market Cap 3.7B TWD
Gross Margin
68%
Country FR
Market Cap 176.4B EUR
Gross Margin
74%
Country UK
Market Cap 113.2B GBP
Gross Margin
0%
Country IN
Market Cap 5.6T INR
Gross Margin
52%
Country UK
Market Cap 33.1B GBP
Gross Margin
62%
Country DE
Market Cap 27.9B EUR
Gross Margin
58%
Country US
Market Cap 23.3B USD
Gross Margin
72%
Country JP
Market Cap 2.9T JPY
Gross Margin
38%
Country IN
Market Cap 1.2T INR
Gross Margin
56%
Country IN
Market Cap 900.4B INR
Gross Margin
49%
Country US
Market Cap 9.4B USD
Gross Margin
34%

Profitability Report

View the profitability report to see the full profitability analysis for Maxigen Biotech Inc.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
68.1%
=
Gross Profit
415.1m
/
Revenue
609.2m
What is the Gross Margin of Maxigen Biotech Inc?

Based on Maxigen Biotech Inc's most recent financial statements, the company has Gross Margin of 68.1%.